{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:34:51Z","timestamp":1774733691868,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014658","name":"Society for the Advancement of Anaesthesia in Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mce.2017.07.024","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T16:15:58Z","timestamp":1500999358000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice"],"prefix":"10.1016","volume":"460","author":[{"given":"Nupur M.","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.B.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-1013","authenticated-orcid":false,"given":"Victor A.","family":"Gault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2017.07.024_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s40265-013-0112-5","article-title":"11\u03b2-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease","volume":"73","author":"Anderson","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.mce.2017.07.024_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/187153007780832082","article-title":"Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity?","volume":"7","author":"Atanasov","year":"2007","journal-title":"Endocr. Metab. Immun. Disord. Drug Targets"},{"key":"10.1016\/j.mce.2017.07.024_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2013.03.009","article-title":"A\u00a0novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties","volume":"85","author":"Bhat","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2017.07.024_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbr.2016.10.033","article-title":"Lixisenatide attenuates the detrimental effects of amyloid \u03b2 protein on spatial working memory and hippocampal neurons in rats","volume":"318","author":"Cai","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mce.2017.07.024_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopha.2015.12.013","article-title":"Role of epigallocatechin-3-gallate in health and disease: a perspective","volume":"78","author":"Chowdhury","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mce.2017.07.024_bib6","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/db13-1609","article-title":"GLP-1\/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet","volume":"63","author":"Clemmensen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2017.07.024_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/jpet.114.215293","article-title":"The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases \u03b2-cell mass without affecting islet number in db\/db mice","volume":"350","author":"Dalb\u00f8ge","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2017.07.024_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2003.11.160","article-title":"Increased expression and activity of 11[beta]-HSD1 in diabetic islets and prevention with troglitazone","volume":"313","author":"Duplomb","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2017.07.024_bib9","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from Guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.07.024_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A\u00a0rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2017.07.024_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2017.07.024_bib12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.ejcn.1602806","article-title":"Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose homeostasis","volume":"62","author":"Fukino","year":"2008","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.mce.2017.07.024_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ijo.2010.59","article-title":"Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet","volume":"34","author":"Gault","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.mce.2017.07.024_bib14","doi-asserted-by":"crossref","first-page":"35581","DOI":"10.1074\/jbc.M113.512046","article-title":"A\u00a0novel glucagon-like peptide-1 (GLP-1)\/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice","volume":"288","author":"Gault","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.07.024_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","article-title":"Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice","volume":"33","author":"Gengler","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mce.2017.07.024_bib16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/dom.12735","article-title":"Robust anti-obesity and metabolic effects of a dual GLP-1\/glucagon receptor peptide agonist in rodents and non-human primates","volume":"18","author":"Henderson","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib17","doi-asserted-by":"crossref","first-page":"e84468","DOI":"10.1371\/journal.pone.0084468","article-title":"Green tea and one of its constituents, epigallocatechin-3-gallate, are potent inhibitors of human 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"9","author":"Hintzpeter","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2017.07.024_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/psc.861","article-title":"Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob\/ob) mice","volume":"13","author":"Irwin","year":"2007","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.mce.2017.07.024_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1463-1326.2009.01036.x","article-title":"Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice","volume":"11","author":"Irwin","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib20","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2337\/db15-0220","article-title":"A\u00a0novel CCK-8\/GLP-1 hybrid peptide exhibiting prominent insulinotropic, glucose-lowering, and satiety actions with significant therapeutic potential in high-fat-fed mice","volume":"64","author":"Irwin","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2017.07.024_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/endo.141.3.7368","article-title":"Modulation of endocrine systems and food intake by green tea epigallocatechin gallate","volume":"141","author":"Kao","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.07.024_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"262","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2017.07.024_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2015.11.019","article-title":"Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice","volume":"420","author":"Millar","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2017.07.024_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/dmrr.2608","article-title":"Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL\/KsJ db\/db mice with degenerative diabetes","volume":"31","author":"Moffett","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.mce.2017.07.024_bib25","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1210\/en.2003-1674","article-title":"Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease","volume":"145","author":"Morton","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2017.07.024_bib26","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.3390\/nu8090552","article-title":"Anticancer efficacy of polyphenols and their combinations","volume":"8","author":"Niedzwiecki","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.mce.2017.07.024_bib27","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1021\/jf102840w","article-title":"Green and black tea suppresses hyperglycaemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL\/6J mice","volume":"58","author":"Nishiumi","year":"2010","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.mce.2017.07.024_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mce.2016.05.012","article-title":"Novel dual agonist peptide analogues derived from dogfish glucagon show promising in\u00a0vitro insulin releasing actions and antihyperglycaemic activity in mice","volume":"431","author":"O'Harte","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2017.07.024_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-7075-9-11","article-title":"Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db\/db mice","volume":"9","author":"Orts\u00e4ter","year":"2012","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1573399810666140707092506","article-title":"Effect of GLP-1 based therapies on diabetic dyslipidemia","volume":"10","author":"Patel","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.mce.2017.07.024_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1463-1326.2010.01259.x","article-title":"Gault. Four weeks administration of liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance","volume":"12","author":"Porter","year":"2010","journal-title":"Diabetes Obes. Metab."},{"issue":"2003","key":"10.1016\/j.mce.2017.07.024_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0955-2863(03)00054-8","article-title":"Effect of EGCG on lipid absorption and plasma lipid levels in rats","volume":"14","author":"Raederstorff","year":"2003","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.mce.2017.07.024_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(96)00135-8","article-title":"Bioactive peptides from lizard venoms","volume":"61","author":"Raufman","year":"1996","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2017.07.024_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdi.12478","article-title":"Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion","volume":"S1","author":"Reimann","year":"2016","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.mce.2017.07.024_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathophys.2009.07.004","article-title":"Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats","volume":"17","author":"Roghani","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.mce.2017.07.024_bib36","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.00030.2002","article-title":"The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice","volume":"283","author":"Rolin","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nn2055","article-title":"Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons","volume":"11","author":"Stranahan","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mce.2017.07.024_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nlm.2008.05.005","article-title":"Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels","volume":"90","author":"Stranahan","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.mce.2017.07.024_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2014.11.008","article-title":"Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis","volume":"37","author":"Sun","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.mce.2017.07.024_bib40","doi-asserted-by":"crossref","first-page":"E1305","DOI":"10.3390\/molecules21101305","article-title":"Nakamura. Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity","volume":"21","author":"Suzuki","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.mce.2017.07.024_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrendo.2016.86","article-title":"Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus","volume":"10","author":"Tahrani","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2017.07.024_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/dom.12390","article-title":"Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents","volume":"17","author":"Trevaskis","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tem.2016.03.004","article-title":"Glucagon-like peptide 1 analogs and their effects on pancreatic islets","volume":"5","author":"Tudur\u00ed","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.07.024_bib44","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/jn\/136.10.2512","article-title":"Epigallocatechin gallate supplementation alleviates diabetes in rodents","volume":"136","author":"Wolfram","year":"2006","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.mce.2017.07.024_bib45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jdi.12495","article-title":"Novel extrapancreatic effects of incretin","volume":"S1","author":"Yamada","year":"2016","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.mce.2017.07.024_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mnfr.201500428","article-title":"Mechanisms of body weight reduction and metabolic syndrome alleviation by tea","volume":"60","author":"Yang","year":"2016","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717303970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717303970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:06:20Z","timestamp":1759586780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720717303970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"alternative-id":["S0303720717303970"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2017.07.024","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2017.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}